Why GH-Axis Research Peptides Are Measured in mg, Not IU…

For laboratory and research use only. Not for human consumption.

Anyone reading across both growth hormone literature and synthetic secretagogue peptide literature runs into an inconsistency fast: one body of work talks in International Units (IU), the other talks in milligrams (mg). This is not a labeling accident or a sign that one field is doing it wrong. The two units measure genuinely different properties, and understanding why clears up a recurring source of confusion in lab settings.

Key Facts

IU (International Unit) is a measure of biological potency, standardized against a reference preparation.
Mg (milligram) is a measure of physical mass, independent of biological activity.
Growth hormone itself has historically been measured in IU because early preparations varied in purity and activity batch to batch.
Synthetic secretagogue peptides are measured in mg because solid-phase synthesis produces material of known, consistent purity.
Confusion typically arises when researchers cross between GH literature (IU-based) and secretagogue peptide literature (mg-based).

Two Different Questions, Two Different Units

A mass unit like milligrams answers the question: how much physical material is present. A potency unit like International Units answers a different question entirely: how biologically active is this material, relative to an agreed reference standard. These are not two ways of saying the same thing. Two samples can contain identical mass and have different biological activity if their purity or structural integrity differs, and conversely, an IU-based measurement can describe activity without directly telling you the mass of material producing it. Keeping this distinction straight is the entire key to understanding why the GH-axis literature uses two different labeling systems depending on what is being discussed.

Why Growth Hormone Is Measured in IU

Growth hormone measurement in International Units has its roots in a period when hormone preparations, including pituitary-derived material, could vary meaningfully in purity and biological activity from one production lot to the next. A potency-based unit solved a practical problem: it let researchers and manufacturers express dose in terms of biological effect rather than raw mass, so that two preparations with different purity levels could still be compared on a common, functionally meaningful scale. This is why growth hormone literature, including recombinant growth hormone research, has generally continued to use IU as its standard measurement, even as manufacturing precision has improved over time. It is a legacy convention rooted in a real historical need for a potency-normalized unit.

Why Synthetic Secretagogue Peptides Are Measured in mg

Peptides like Ipamorelin, CJC-1295, and Tesamorelin are produced through solid-phase peptide synthesis, a manufacturing process that builds a peptide chain residue by residue under controlled conditions. This process, combined with modern purification and verification methods such as HPLC and mass spectrometry, allows a manufacturer to characterize a batch to a known, consistent level of purity. Once purity is well characterized and consistent, mass becomes a precise and directly verifiable descriptor: a given milligram quantity of a peptide verified at a stated purity level corresponds to a known quantity of the actual molecule. There is no need for a potency-normalization step the way there historically was for variable hormone preparations, because the identity and purity of the synthesized peptide can be confirmed analytically before it is ever labeled. This is why the secretagogue peptide literature, and product labeling in this space, is built around milligrams rather than International Units.

Where the Confusion Actually Comes From

The confusion almost never comes from either unit being used incorrectly within its own field. It comes from researchers moving between fields. Someone reading growth hormone axis literature broadly will encounter IU-based figures in older or hormone-specific papers, then encounter mg-based figures in secretagogue peptide papers discussing compounds that are mechanistically related (both are part of GH-axis research) but structurally and analytically distinct substances. Treating the two units as interchangeable, or assuming a simple conversion factor exists between them, is the specific error worth avoiding. A conversion factor between IU and mg, where one exists at all, applies only to a specific substance measured against a specific reference standard, and does not generalize to other peptides.

Practical Implications for Reconstitution Math

For lab work involving reconstitution and concentration calculations, this distinction has direct consequences. Calculations for a mg-labeled synthetic peptide are mass-based: a known mg quantity dissolved into a known volume yields a known mg/mL concentration, which is a straightforward mass-per-volume calculation. This is categorically different arithmetic from working with an IU-labeled hormone preparation, where the labeled quantity reflects potency rather than mass, and mass-per-volume figures are not directly interchangeable with the IU figure on the label. Our mg/mL concentration quick-reference chart and our more detailed molarity vs. mass concentration calculation guide both work from the mg-based framework that applies to synthetic secretagogue peptides. For hands-on concentration math, our reconstitution calculator is built around mass-based inputs consistent with how compounds like these are labeled.

Applying This to Specific Compounds

Compounds such as our Tesamorelin research compound and our CJC-1295 (no DAC) and Ipamorelin combination are labeled in mg for exactly the reasons described above: they are synthetic peptides with analytically verified purity, and mass is the precise, directly meaningful unit for describing quantity. Recognizing this units distinction is a matter of laboratory literacy, not dosing guidance, and it becomes especially relevant for anyone doing concentration math that spans literature from both the hormone side and the secretagogue peptide side of GH-axis research.

FAQ

What does IU actually measure

IU, or International Unit, is a measure of biological activity or potency rather than physical mass. It was standardized historically for hormone preparations, including growth hormone, where purity and activity could vary between production batches, so a potency-based unit allowed comparable dosing across batches with different actual mass content.

Why are secretagogue peptides like Ipamorelin labeled in mg instead of IU

Synthetic peptides manufactured through solid-phase peptide synthesis can be produced and verified to a known, consistent purity, so a milligram measurement directly corresponds to a known quantity of molecule. A mass-based unit is more precise and more directly verifiable than a potency-based unit when the material's purity is already well characterized.

Where does the IU versus mg confusion usually come from

It typically comes from researchers moving between two different bodies of literature: growth hormone literature, which has historically used IU as its standard unit, and synthetic secretagogue peptide literature, which uses mg. Because both areas relate to the GH axis, it is easy to assume the units are interchangeable when they measure fundamentally different things.

Can IU and mg be converted directly into each other

Not directly and not universally. IU is a potency measure specific to a particular biological reference standard, while mg is a mass measure. A conversion factor between the two only applies to the specific substance and reference standard it was defined for, and it does not generalize across different peptides.

Is this explanation intended as dosing guidance

No. This article explains units and measurement concepts for laboratory and research literacy purposes only. It does not provide dosing instructions or human use guidance.